Express Pharma

We are witnessing a lot of positive disruption in healthcare in the Asian region

Amit Chopra, MD – India and South Asia, Thermo Fisher Scientific speaks on the disruptions in the healthcare space, Thermo Fisher Scientific's offerings for the life sciences industry, lessons from the pandemic and more, in an exclusive interaction with Ashwini Prakash, Managing Partner and Board Director - Singapore and India, Stanton Chase

0 957

Thermo Fisher is classified as an essential services provider, how did you contribute to India’s response in tackling the pandemic?

Undoubtedly, we were in uncharted waters with the pandemic and there were a lot of uncertainties. What worked in our favour was the ecosystem we had built over the years. We had a multi-year relationship and engagement with the National Institute of Virology (NIV). We provided them with essential components for the development of Covid testing kits. We worked closely with regulators such as the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI), and got